Printer Friendly

BIOGEN APPOINTS MULLEN TO VICE PRESIDENT-OPERATIONS

 BIOGEN APPOINTS MULLEN TO VICE PRESIDENT-OPERATIONS
 CAMBRIDGE, Mass., Dec. 16 /PRNewswire/ -- Biogen, Inc.


(NASDAQ: BGEN) today announced the appointment of James C. Mullen to the position of vice president-Operations. Mullen, who previously was senior director of Operations, will continue to be responsible for all process development, manufacturing and facilities management of the company.
 Mullen joined Biogen in 1989 as director of Facilities and Engineering. He was promoted to his present duties in 1990. Prior to arriving at Biogen, Mullen was employed by SmithKline & French International in various management positions. Mullen holds a B.S. from Rensselaer Polytechnic Institute and an M.B.A. from Villanova University.
 Biogen, Inc., headquartered in Cambridge, Mass., is a biopharmaceutical company principally engaged in developing and manufacturing drugs from human healthcare through genetic engineering. The company's revenues are generated from the worldwide sales by licensees of five products, including alpha interferon, hepatitis vaccines and hepatitis diagnostic products. Biogen is focused primarily on developing and testing products for the treatment of cardiovascular disease, inflammatory diseases, AIDS and certain cancers.
 -0- 12/16/91
 /CONTACT: Kenneth M. Bate of Biogen, 617-252-9200/
 (BGEN) CO: Biogen, Inc. ST: Massachusetts IN: MTC SU: PER


SH -- NE006 -- 2463 12/16/91 11:21 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 16, 1991
Words:203
Previous Article:MCI OFFERS UP TO 35 PERCENT SAVINGS ON CHRISTMAS AND NEW YEAR'S DAY CALLS
Next Article:BIOGEN, INC. APPOINTS AMY D. SELTZER AS DIRECTOR -- INVESTOR RELATIONS
Topics:


Related Articles
BIOGEN APPOINTS LAWRENCE S. DANIELS VICE PRESIDENT-MARKETING AND BUSINESS DEVELOPMENT
BIOGEN, INC. APPOINTS AMY D. SELTZER AS DIRECTOR -- INVESTOR RELATIONS
BIOGEN, INC. APPOINTS DR. IAN HIRST AS DIRECTOR OF MANUFACTURING
BIOGEN ANNOUNCES MANAGEMENT REALIGNMENT AS NEXT STEP IN TRANSITION FROM R&D ORGANIZATION TO OPERATING COMPANY
BIOGEN APPOINTS DAVID DLESK AS SENIOR DIRECTOR OF MANUFACTURING AND ENGINEERING

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters